Abbott profit forecast gets a lift from St. Jude integration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Abbott Labs (ABT) PT Raised to $56 at Deutsche Bank Following 2Q
July 21, 2017 8:37 AM EDTDeutsche Bank raised its price target on Abbott Labs (NYSE: ABT) to $56.00 (from $49.00) while maintaining a Buy rating following 2Q earnings report.... More
Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'
July 21, 2017 8:32 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) while maintaining a Overweight rating, following the company's second quarter earnings announcement.
Analyst Matthew Taylor notes the company delivered second quarter earnings per share and revenue results above the Street's... More
Abbott Labs (ABT) PT Raised to $62 at Argus on 2Q Beat & FY17 Raise; 'Positive View of Growth Prospects'
July 21, 2017 7:45 AM EDTArgus raised its price target on Abbott Labs (NYSE: ABT) to $62.00 (from $55.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst David Toung notes the company delivered second quarter earnings per share above consensus projections driven by positive... More
